Skip to content
MedsAcross

Medicine

Insulin Diluting Medium for Garzulys 1 mL/mL injection

Water · Intravenous, subcutaneous · Meitheal Pharmaceuticals
Available on requestPrescription onlyUS FDA Cold chain

Insulin Diluting Medium for Garzulys 1 mL/mL injection is a prescription medicine containing Water for intravenous, subcutaneous use, marketed by Meitheal Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Store unused Garzulys in a refrigerator between 2°C to 8°C (36°F to 46°F). Do…

Key facts

Active ingredient (INN)
Water
Brand
Insulin Diluting Medium for Garzulys
Strength
1 mL/mL
Dosage form
Injection
Route
Intravenous, subcutaneous
Packs
1 vial
Marketing authorisation holder
Meitheal Pharmaceuticals
Manufacturer
Meitheal Pharmaceuticals
Origin register
US FDA, United States
Storage
Store unused Garzulys in a refrigerator between 2°C to 8°C (36°F to 46°F). Do not freeze Garzulys and do not use Garzulys if it has been frozen. Storage Conditions for Garzulys Vial and Prefilled Pen Garzulys presentation Not in-use (unopened) Room Temperature (up to 30°C [86°F]) Not in-use (unopened) Refrigerated (2°C to 8°C [36°F to 46°F]) In-use (opened) Room Temperature (up to 30°C [86°F]) 10…
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3002.15Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
24 July 2026
Identifiers
RxCUI 2748451, 2748457, 2748459 +1DailyMed set ID 30c64769-d2f7-4604-ac9e-2a6bc09506c9NDC 71288-909Application BLA761497

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 vial, glass in 1 carton / 10 mL in 1 vial, glass71288-909-10Meitheal Pharmaceuticals24 July 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Water 1 mL/mL injection.

Compare all 10

Other strengths and forms of Water

Clinical summary

Water is a prescription medicine indicated as an irrigating fluid or pharmaceutic aid. It is available as injection and irrigation solution for intravenous, subcutaneous and intramuscular use. MedsAcross supplies Water for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Water

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Insulin Diluting Medium for Garzulys 1 mL/mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.